← Back to catalogue

Validate

FDA UDI

Class I (US FDA UDI)

by LGC Clinical Diagnostics, Inc.

Identity

Trade Name
Validate FDA UDI
Generic Name
Cystatin C IVD, control FDA UDI
Device Name
Validate Diabetes is intended for the quantitative determination of Calibration Verification/Linearity on automated instruments. FDA UDI
Model / Reference
204ro FDA UDI
Description
Validate Diabetes is intended for the quantitative determination of Calibration Verification/Linearity on automated instruments. FDA UDI

Identifiers

Catalog Number
204ro FDA UDI
Primary DI / UDI-DI
00850011135273 FDA UDI
FDA Product Code
JJY FDA UDI
GMDN Term
Cystatin C IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Beta-hydroxybutyrate IVD, controlInsulin IVD, controlCystatin C IVD, controlC-peptide IVD, control

Validate by LGC Clinical Diagnostics, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Fructosamine IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI c875af5d-dd94-460e-bd39-0e0366ac2502 37 fields · synced Jun 9, 2026